Request Sample Inquiry
Epigenetics Market

Epigenetics Market

Epigenetics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

140

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1339

Segments Covered
  • By Product By Product Instruments, Reagents & Kits, Others
  • By Application By Application Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, Others
  • By Technology By Technology Methylation, Acetylation, Phosphorylation, Other Technologies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.9 Billion
Revenue 2030Revenue 2030: USD 4.41 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 12.80%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Epigenetics Market - Segment Analysis
    1. Overview
    2. Global Epigenetics Market, 2016 - 2028 (USD Million)
    3. Global Epigenetics Market - by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. Global Epigenetics Market - by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. Global Epigenetics Market - by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. Global Epigenetics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Epigenetics Market - Segment Analysis
    1. Overview
    2. North America Epigenetics Market, 2016 - 2028 (USD Million)
    3. North America Epigenetics Market, by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. North America Epigenetics Market, by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. North America Epigenetics Market, by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. North America Epigenetics Market, by Country
      1. U.S.
        1. U.S. Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. U.S. Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. U.S. Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      2. Canada
        1. Canada Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Canada Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Canada Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      3. Mexico
        1. Mexico Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Mexico Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Mexico Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
  5. Europe Epigenetics Market - Segment Analysis
    1. Overview
    2. Europe Epigenetics Market, 2016 - 2028 (USD Million)
    3. Europe Epigenetics Market, by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. Europe Epigenetics Market, by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. Europe Epigenetics Market, by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. Europe Epigenetics Market, by Country
      1. Germany
        1. Germany Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Germany Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Germany Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      2. UK
        1. UK Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. UK Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. UK Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      3. France
        1. France Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. France Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. France Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      4. Spain
        1. Spain Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Spain Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Spain Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      5. Italy
        1. Italy Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Italy Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Italy Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      6. BENELUX
        1. BENELUX Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. BENELUX Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. BENELUX Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      7. Rest of Europe
        1. Rest Of Europe Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Rest Of Europe Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Rest Of Europe Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
  6. Asia Pacific Epigenetics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Epigenetics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Epigenetics Market, by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. Asia Pacific Epigenetics Market, by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. Asia Pacific Epigenetics Market, by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. Asia Pacific Epigenetics Market, by Country
      1. China
        1. China Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. China Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. China Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      2. Japan
        1. Japan Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Japan Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Japan Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      3. India
        1. India Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. India Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. India Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      4. South Korea
        1. South Korea Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. South Korea Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. South Korea Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      5. South East Asia
        1. South East Asia Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. South East Asia Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. South East Asia Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Rest of Asia Pacific Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Rest of Asia Pacific Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
  7. Latin America Epigenetics Market - Segment Analysis
    1. Overview
    2. Latin America Epigenetics Market, 2016 - 2028 (USD Million)
    3. Latin America Epigenetics Market, by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. Latin America Epigenetics Market, by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. Latin America Epigenetics Market, by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. Latin America Epigenetics Market, by Country
      1. Brazil
        1. Brazil Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Brazil Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Brazil Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      2. Argentina
        1. Argentina Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Argentina Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Argentina Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      3. Rest of Latin America
        1. Rest of Latin America Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Rest of Latin America Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Rest of Latin America Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
  8. Middle East & Africa Epigenetics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Epigenetics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Epigenetics Market, by Product
      1. By Instruments
      2. By Reagents & Kits
      3. By Others
    4. Middle East & Africa Epigenetics Market, by Application
      1. By Oncology
      2. By Autoimmune Diseases
      3. By Metabolic Diseases
      4. By CNS/Pain Diseases
      5. By Cardiovascular Diseases
      6. By Others
    5. Middle East & Africa Epigenetics Market, by Technology
      1. By Methylation
      2. By Acetylation
      3. By Phosphorylation
      4. By Other Technologies
    6. Middle East & Africa Epigenetics Market, by Country
      1. GCC Countries
        1. GCC Countries Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. GCC Countries Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. GCC Countries Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      2. South Africa
        1. South Africa Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. South Africa Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. South Africa Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Epigenetics Market, By Product
          1. By Instruments
          2. By Reagents & Kits
          3. By Others
        2. Rest of Middle East & Africa Epigenetics Market, By Application
          1. By Oncology
          2. By Autoimmune Diseases
          3. By Metabolic Diseases
          4. By CNS/Pain Diseases
          5. By Cardiovascular Diseases
          6. By Others
        3. Rest of Middle East & Africa Epigenetics Market, By Technology
          1. By Methylation
          2. By Acetylation
          3. By Phosphorylation
          4. By Other Technologies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Illumina (US)
    2. Thermo Fisher Scientific (US)
    3. Merck Millipore (US)
    4. Abcam (UK)
    5. Active Motif (US)
    6. Bio-Rad Laboratories (US)
    7. New England Biolabs (US)
    8. Agilent (US)
    9. QIAGEN (Netherlands)
    10. Zymo Research (US)
    11. PerkinElmer (US)
    12. and Diagenode (Belgium) are the major companies operating in Epigenetics Market.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Epigenetics valued at USD 1.9 Billion in 2022 and is expected to reach USD 4.41 Billion in 2030 growing at a CAGR of 12.80%.

  • The prominent players in the market are Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad Laboratories (US), New England Biolabs (US), Agilent (US), QIAGEN (Netherlands), Zymo Research (US), PerkinElmer (US), and Diagenode (Belgium) are the major companies operating in Epigenetics Market..

  • The market is project to grow at a CAGR of 12.80% between 2023 and 2030.

  • The driving factors of the Epigenetics include

    • Rising Cancer Prevalence

  • North America was the leading regional segment of the Epigenetics in 2022.